Taikang Asset Management (Hong Kong) CO LTD Verona Pharma PLC Transaction History
Taikang Asset Management (Hong Kong) CO LTD
- $641 Million
- Q2 2024
A detailed history of Taikang Asset Management (Hong Kong) CO LTD transactions in Verona Pharma PLC stock. As of the latest transaction made, Taikang Asset Management (Hong Kong) CO LTD holds 50,000 shares of VRNA stock, worth $1.44 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$1.44 Million% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
137Shares Held
66.7MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$219 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$160 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$115 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$102 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$95.2 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $1.75B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...